{"name":"Biosensia","permalink":"biosensia","crunchbase_url":"http://www.crunchbase.com/company/biosensia","homepage_url":"http://www.biosensia.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2006,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@biosensia.com","phone_number":"+353 1 7163650","description":"in-vitro diagnostics company","created_at":"Wed Dec 23 08:23:50 UTC 2009","updated_at":"Wed Aug 22 19:58:56 UTC 2012","overview":"<p>Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. </p>\n\n<p>RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. </p>\n\n<p>Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.</p>","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/0952/70952v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0007/0952/70952v1-max-250x250.jpg"],[[297,71],"assets/images/resized/0007/0952/70952v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Diarmuid","last_name":"Flavin","permalink":"diarmuid-flavin","image":null}},{"is_past":true,"title":"COO","person":{"first_name":"Diarmuid","last_name":"Flavin","permalink":"diarmuid-flavin-2","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$4.13M","funding_rounds":[{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":2930000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":5,"investments":[{"company":null,"financial_org":{"name":"Street Capital","permalink":"street-capital","image":{"available_sizes":[[[150,23],"assets/images/resized/0007/6748/76748v1-max-150x150.jpg"],[[250,38],"assets/images/resized/0007/6748/76748v1-max-250x250.jpg"],[[450,70],"assets/images/resized/0007/6748/76748v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Enterprise Ireland","permalink":"enterprise-ireland","image":{"available_sizes":[[[150,45],"assets/images/resized/0005/2364/52364v1-max-150x150.jpg"],[[210,63],"assets/images/resized/0005/2364/52364v1-max-250x250.jpg"],[[210,63],"assets/images/resized/0005/2364/52364v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Seroba Kernel","permalink":"seroba-bioventures","image":{"available_sizes":[[[150,87],"assets/images/resized/0007/6008/76008v1-max-150x150.jpg"],[[250,145],"assets/images/resized/0007/6008/76008v1-max-250x250.jpg"],[[300,175],"assets/images/resized/0007/6008/76008v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Atlantic Bridge","permalink":"atlantic-bridge","image":{"available_sizes":[[[150,53],"assets/images/resized/0003/1834/31834v1-max-150x150.png"],[[240,86],"assets/images/resized/0003/1834/31834v1-max-250x250.png"],[[240,86],"assets/images/resized/0003/1834/31834v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/12/biosensia-raises-e1-2m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Biosensia Raises â‚¬1.2M in Funding","raised_amount":1200000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":12,"funded_day":19,"investments":[{"company":null,"financial_org":{"name":"ACT Venture Capital","permalink":"act-venture-capital","image":{"available_sizes":[[[150,48],"assets/images/resized/0004/4439/44439v1-max-150x150.jpg"],[[181,58],"assets/images/resized/0004/4439/44439v1-max-250x250.jpg"],[[181,58],"assets/images/resized/0004/4439/44439v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Seroba Bioventures","permalink":"seroba-bioventures-2","image":null},"person":null},{"company":null,"financial_org":{"name":"Atlantic Bridge","permalink":"atlantic-bridge","image":{"available_sizes":[[[150,53],"assets/images/resized/0003/1834/31834v1-max-150x150.png"],[[240,86],"assets/images/resized/0003/1834/31834v1-max-250x250.png"],[[240,86],"assets/images/resized/0003/1834/31834v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"HQ","address1":"Belfield Innovation Park","address2":"","zip_code":"","city":"Dublin","state_code":null,"country_code":"IRL","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,109],"assets/images/resized/0007/0953/70953v1-max-150x150.jpg"],[[250,183],"assets/images/resized/0007/0953/70953v1-max-250x250.jpg"],[[450,329],"assets/images/resized/0007/0953/70953v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}